Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,587 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer.
Kishan AU, Dang A, Katz AJ, Mantz CA, Collins SP, Aghdam N, Chu FI, Kaplan ID, Appelbaum L, Fuller DB, Meier RM, Loblaw DA, Cheung P, Pham HT, Shaverdian N, Jiang N, Yuan Y, Bagshaw H, Prionas N, Buyyounouski MK, Spratt DE, Linson PW, Hong RL, Nickols NG, Steinberg ML, Kupelian PA, King CR. Kishan AU, et al. Among authors: cheung p. JAMA Netw Open. 2019 Feb 1;2(2):e188006. doi: 10.1001/jamanetworkopen.2018.8006. JAMA Netw Open. 2019. PMID: 30735235 Free PMC article.
Effect of combined treatment with salvage radiotherapy plus androgen suppression on quality of life in patients with recurrent prostate cancer after radical prostatectomy.
Pearce A, Choo R, Danjoux C, Morton G, Loblaw DA, Szumacher E, Cheung P, Deboer G, Chander S. Pearce A, et al. Among authors: cheung p. Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):78-83. doi: 10.1016/j.ijrobp.2005.11.041. Epub 2006 Mar 24. Int J Radiat Oncol Biol Phys. 2006. PMID: 16563657 Clinical Trial.
Hypofractionated accelerated radiotherapy using concomitant intensity-modulated radiotherapy boost technique for localized high-risk prostate cancer: acute toxicity results.
Lim TS, Cheung PC, Loblaw DA, Morton G, Sixel KE, Pang G, Basran P, Zhang L, Tirona R, Szumacher E, Danjoux C, Choo R, Thomas G. Lim TS, et al. Among authors: cheung pc. Int J Radiat Oncol Biol Phys. 2008 Sep 1;72(1):85-92. doi: 10.1016/j.ijrobp.2007.12.041. Epub 2008 Mar 20. Int J Radiat Oncol Biol Phys. 2008. PMID: 18355982 Clinical Trial.
Analysis of gastrointestinal and genitourinary morbidity of postoperative radiotherapy for pathologic T3 disease or positive surgical margins after radical prostatectomy using national cancer institute expanded common toxicity criteria.
Choo R, Pearse M, Danjoux C, Gardner S, Morton G, Szumacher E, Loblaw DA, Cheung P. Choo R, et al. Among authors: cheung p. Int J Radiat Oncol Biol Phys. 2008 Nov 15;72(4):989-95. doi: 10.1016/j.ijrobp.2008.02.044. Epub 2008 Apr 23. Int J Radiat Oncol Biol Phys. 2008. PMID: 18436391 Clinical Trial.
Prospective assessment of gastrointestinal and genitourinary toxicity of salvage radiotherapy for patients with prostate-specific antigen relapse or local recurrence after radical prostatectomy.
Pearse M, Choo R, Danjoux C, Gardner S, Morton G, Szumacher E, Loblaw A, Cheung P. Pearse M, et al. Among authors: cheung p. Int J Radiat Oncol Biol Phys. 2008 Nov 1;72(3):792-8. doi: 10.1016/j.ijrobp.2008.05.063. Epub 2008 Aug 15. Int J Radiat Oncol Biol Phys. 2008. PMID: 18707818
Prospective study evaluating postoperative radiotherapy plus 2-year androgen suppression for post-radical prostatectomy patients with pathologic T3 disease and/or positive surgical margins.
Choo R, Danjoux C, Gardner S, Morton G, Szumacher E, Loblaw DA, Cheung P, Pearse M. Choo R, et al. Among authors: cheung p. Int J Radiat Oncol Biol Phys. 2009 Oct 1;75(2):407-12. doi: 10.1016/j.ijrobp.2008.11.007. Epub 2009 Feb 11. Int J Radiat Oncol Biol Phys. 2009. PMID: 19211197
1,587 results